Thomas A Sellers

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 11:1104-7. 2002
  2. ncbi request reprint Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Am J Epidemiol 155:225-33. 2002
  3. ncbi request reprint Evaluation of a program to train nurses to screen for breast and cervical cancer among Native American women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic Cancer Center, Rochester, Minnesota 55905, USA
    J Cancer Educ 17:24-7. 2002
  4. ncbi request reprint Review of proteomics with applications to genetic epidemiology
    Thomas A Sellers
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Genet Epidemiol 24:83-98. 2003
  5. pmc Association between mammographic density and age-related lobular involution of the breast
    Karthik Ghosh
    Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 28:2207-12. 2010
  6. pmc Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 18:935-44. 2009
  7. ncbi request reprint A comprehensive examination of CYP19 variation and breast density
    Janet E Olson
    Division of Epidemiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55901, USA
    Cancer Epidemiol Biomarkers Prev 16:623-5. 2007
  8. ncbi request reprint Longitudinal trends in mammographic percent density and breast cancer risk
    Celine M Vachon
    Mayo Clinic College of Medicine, Charlton 6 239, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 16:921-8. 2007
  9. pmc Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study
    Pamela S Sinicrope
    Mayo Clinic, College of Medicine, Behavioral Science Research, Rochester, MN 55901, USA
    Psychooncology 18:169-78. 2009
  10. pmc A novel automated mammographic density measure and breast cancer risk
    John J Heine
    Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Natl Cancer Inst 104:1028-37. 2012

Detail Information

Publications88

  1. ncbi request reprint Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 11:1104-7. 2002
    ....
  2. ncbi request reprint Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Am J Epidemiol 155:225-33. 2002
    ..9, 5.8). Thus, the previously reported interaction between family history and waist/hip ratio is still (weakly) evident and appears to reflect risk for progesterone receptor-negative tumors...
  3. ncbi request reprint Evaluation of a program to train nurses to screen for breast and cervical cancer among Native American women
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic Cancer Center, Rochester, Minnesota 55905, USA
    J Cancer Educ 17:24-7. 2002
    ....
  4. ncbi request reprint Review of proteomics with applications to genetic epidemiology
    Thomas A Sellers
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Genet Epidemiol 24:83-98. 2003
    ..Several examples are presented to illustrate the potential application of proteomics to the field of genetic epidemiology, and we conclude with various considerations regarding design and analysis...
  5. pmc Association between mammographic density and age-related lobular involution of the breast
    Karthik Ghosh
    Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 28:2207-12. 2010
    ..We examined the involution and density association in a large benign breast disease (BBD) cohort...
  6. pmc Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 18:935-44. 2009
    ..These results exemplify the utility of imputation in candidate gene studies and lend evidence to a role of cell cycle genes in ovarian cancer etiology, suggest a reduced set of SNPs to target in additional cases and controls...
  7. ncbi request reprint A comprehensive examination of CYP19 variation and breast density
    Janet E Olson
    Division of Epidemiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55901, USA
    Cancer Epidemiol Biomarkers Prev 16:623-5. 2007
  8. ncbi request reprint Longitudinal trends in mammographic percent density and breast cancer risk
    Celine M Vachon
    Mayo Clinic College of Medicine, Charlton 6 239, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 16:921-8. 2007
    ..Mammographic density is a strong risk factor for breast cancer. However, whether changes in mammographic density are associated with risk remains unclear...
  9. pmc Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study
    Pamela S Sinicrope
    Mayo Clinic, College of Medicine, Behavioral Science Research, Rochester, MN 55901, USA
    Psychooncology 18:169-78. 2009
    ..Using survey data from 2328 women (mean age 62.5 years) from 372 families enrolled in the Minnesota breast cancer family study, we explored adult daughter's reports of breast cancer risk reduction advice received from their mothers...
  10. pmc A novel automated mammographic density measure and breast cancer risk
    John J Heine
    Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Natl Cancer Inst 104:1028-37. 2012
    ..We developed an automated and objective measurement of the grayscale value variation within a mammogram, evaluated its association with breast cancer, and compared its performance with that of percent density (PD)...
  11. ncbi request reprint Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer
    Yvette N Martin
    Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 15:2322-4. 2006
  12. doi request reprint Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study
    Linda E Kelemen
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Am J Epidemiol 167:1027-36. 2008
    ..These data suggest that menopause, baseline PD, postmenopausal hormone use, and body mass index predict changes in mammographic density trends during adult life...
  13. ncbi request reprint Age-related lobular involution and risk of breast cancer
    Tia R Milanese
    Mayo Medical School, Rochester, MN 55905, USA
    J Natl Cancer Inst 98:1600-7. 2006
    ..As women age, the lobules in their breasts undergo involution or regression. We investigated whether lobular involution in women with benign breast disease was associated with subsequent breast cancer risk...
  14. ncbi request reprint Stratification of breast cancer risk in women with atypia: a Mayo cohort study
    Amy C Degnim
    Division of General Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Oncol 25:2671-7. 2007
    ..Atypical hyperplasia is a well-recognized risk factor for breast cancer, conveying an approximately four-fold increased risk. Data regarding long-term absolute risk and factors for risk stratification are needed...
  15. pmc Relative weight at age 12 and risk of postmenopausal breast cancer
    Aditya Bardia
    Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 17:374-8. 2008
    ....
  16. ncbi request reprint Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort
    James R Cerhan
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 13:1114-20. 2004
    ....
  17. pmc Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women
    Karthik Ghosh
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 17:872-9. 2008
    ..Limited studies have examined the associations between mammographic density and subsequent breast tumor characteristics...
  18. pmc AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study
    Fergus J Couch
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 16:1416-21. 2007
    ..In summary, the F31I polymorphism in AURKA is not associated with a modified risk of breast cancer in BRCA1 and BRCA2 carriers...
  19. pmc Texture features from mammographic images and risk of breast cancer
    Armando Manduca
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 18:837-45. 2009
    ..However, simultaneous inclusion of these features in a model with PD did not significantly improve the ability to predict breast cancer...
  20. pmc Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer
    Abraham Peedicayil
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Gynecol Oncol 114:260-4. 2009
    ..We now examine the hypothesis that inherited alterations in TCEAL7 play a role in the etiology of ovarian cancer...
  21. pmc Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Mol Carcinog 50:397-402. 2011
    ..11, 95% CI: 1.00-1.23, P = 0.04). These findings are consistent with prior studies implicating these genes in carcinogenesis and suggest that this collection of variants is worthy of follow-up in additional studies...
  22. ncbi request reprint Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Res 67:8412-8. 2007
    ..4 cM). The putative locus on chromosome 5p is likely to account for up to 22% of variation in MD. Hence, 1 or more of the 45 candidate genes in this region could explain a large proportion of MD and, potentially, breast cancer...
  23. pmc Body size and incident colorectal cancer: a prospective study of older women
    Amy S Oxentenko
    College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Cancer Prev Res (Phila) 3:1608-20. 2010
    ..e., early adulthood versus later adulthood) might also be informative, particularly with respect to defining subsite-specific pathways of colorectal carcinogenesis...
  24. ncbi request reprint Does folate intake decrease risk of postmenopausal breast cancer among women with a family history?
    Thomas A Sellers
    Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Cancer Causes Control 15:113-20. 2004
    ..We examined whether the putative benefit extends to women with a family history (FH) of breast cancer using a cohort of 33,552 postmenopausal women aged 55-69 years in 1986...
  25. ncbi request reprint ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers
    Camilo Adem
    Division of Laboratory Genetics, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Genes Chromosomes Cancer 41:1-11. 2004
    ....
  26. ncbi request reprint High-folate diets and breast cancer survival in a prospective cohort study
    Thomas A Sellers
    Department of Health Sciences Research, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Nutr Cancer 44:139-44. 2002
    ..These findings, although preliminary, afford some reassurance that folate supplementation is unlikely to have a significant adverse effect on survival after chemotherapy for breast cancer...
  27. pmc Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer
    Kristin L White
    Mayo Clinic College of Medicine, Rochester, MN, USA
    BMC Cancer 9:170. 2009
    ..Inhibitors of kappaB (IkappaB) prevent NF-kappaB activation by sequestering NF-kappaB proteins in the cytoplasm until IkappaB proteins are phosphorylated and degraded...
  28. ncbi request reprint Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status
    Aditya Bardia
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Arch Intern Med 166:2478-83. 2006
    ..The objective of this study was to examine the association of physical activity with breast cancer incidence based on ER/PR status of the tumor...
  29. ncbi request reprint Prenatal and perinatal correlates of adult mammographic breast density
    James R Cerhan
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 14:1502-8. 2005
    ..We examined the hypothesis that those factors associated with higher levels of estrogen during pregnancy or shortly after birth are associated with higher mammographic breast density in adulthood...
  30. pmc Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer
    Kristin L White
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Twin Res Hum Genet 13:43-56. 2010
    ..10). These results indicate that the SNPs studied here are not related to risk of this gynecologic malignancy and that the site-specific nature of 8q24.21.a associations may not include ovarian cancer...
  31. ncbi request reprint Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer
    Janet E Olson
    Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 80:1423-8. 2005
    ..To examine the association of cigarette smoking before first pregnancy with risk of postmenopausal breast cancer in a large population-based cohort...
  32. ncbi request reprint Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA)
    James R Cerhan
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Causes Control 15:1-9. 2004
    ..To determine whether the association of adolescent anthropometric characteristics with breast cancer is modified by a family history of the disease...
  33. pmc Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes
    Brooke L Fridley
    Departments of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 21:529-36. 2012
    ..Gene set analysis (GSA) overcomes this limitation by assessing overall evidence for association of a phenotype with all measured variation in a set of genes...
  34. pmc Assessment of hepatocyte growth factor in ovarian cancer mortality
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 20:1638-48. 2011
    ..Invasive ovarian cancer is a significant cause of gynecologic cancer mortality...
  35. pmc A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Nat Genet 42:874-9. 2010
    ..Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development...
  36. pmc Inherited determinants of ovarian cancer survival
    Ellen L Goode
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Cancer Res 16:995-1007. 2010
    ....
  37. ncbi request reprint Mammographic breast density as a general marker of breast cancer risk
    Celine M Vachon
    Mayo Clinic College of Medicine, Charlton 6 239, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 16:43-9. 2007
    ..Overall mammographic density seems to represent a general marker of breast cancer risk that is not specific to breast side or location of the eventual cancer...
  38. pmc Performance of amplified DNA in an Illumina GoldenGate BeadArray assay
    Julie M Cunningham
    Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 17:1781-9. 2008
    ..We recommend that biological SNP characteristics, notably distance to telomere and GC content (<50% GC recommended), as well as Illumina-provided metrics be considered in the creation of GoldenGate assays using MDA WGA DNA...
  39. ncbi request reprint Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia
    James R Cerhan
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 11:1466-71. 2002
    ..For diffuse NHL, 64% of the cases were nodal, and there was no association of HRT with either nodal or extra-nodal sites. These data suggest that HRT is a risk factor for follicular NHL but not for diffuse or small lymphocyte NHL or CLL...
  40. pmc Inherited variants in regulatory T cell genes and outcome of ovarian cancer
    Ellen L Goode
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
    PLoS ONE 8:e53903. 2013
    ..1×10(-4)) among all cases combined. As the products of these genes are known to affect induction, trafficking, or immunosuppressive function of Tregs, these results suggest the need for follow-up phenotypic studies...
  41. pmc No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Breast Cancer Res 14:R7. 2012
    ....
  42. pmc Ovarian cancer risk associated with inherited inflammation-related variants
    Kristin L White
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Res 72:1064-9. 2012
    ....
  43. pmc Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women's Health Study
    Paul J Limburg
    Mayo Clinic Cancer Center, Rochester, MN 55905, USA
    Int J Cancer 123:2717-9. 2008
    ..Multivariable adjustment yielded slightly attenuated risk estimates, but the observed associations were not meaningfully altered. Given these findings, tFA intake does not appear to be a major CRC risk factor, at least among older women...
  44. ncbi request reprint Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study
    Janet E Olson
    Mayo Foundation, Health Sciences Research, Rochester, Minnesota 55905, USA
    Cancer 94:1612-8. 2002
    ..A recent study reported that women with a hospital discharge diagnosis of endometriosis were at increased risk of cancer at any site, breast cancer, ovarian cancer, and hematopoietic malignancies, especially non-Hodgkin lymphoma (NHL)...
  45. pmc Mammographic density, breast cancer risk and risk prediction
    Celine M Vachon
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Breast Cancer Res 9:217. 2007
    ..Promising new measures of mammographic density, including volumetric density, which can be standardized using full-field digital mammography, will likely result in a stronger risk factor and improve accuracy of risk prediction models...
  46. ncbi request reprint Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study
    James R Cerhan
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Am J Epidemiol 156:527-35. 2002
    ..The opposite associations of body mass index with small lymphocytic lymphoma versus B-CLL may be a chance finding but, if confirmed, would suggest different etiologies for these malignancies...
  47. pmc The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history
    Jon O Ebbert
    Nicotine Research Center, Division of Community Internal Medicine, Rochester, MN 55905, USA
    J Gen Intern Med 20:14-20. 2005
    ..To evaluate the effect of alcohol on coronary heart disease (CHD), cancer incidence, and cancer mortality by smoking history...
  48. pmc A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches
    Janet E Olson
    Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55901, USA
    Breast Cancer Res Treat 102:237-47. 2007
    ..We recently published resequencing data on 88 polymorphisms identified in that gene. The hypothesis tested in this study was that polymorphisms, or haplotypes, in CYP19 are related to risk of breast cancer...
  49. pmc Genetic variation in the one-carbon transfer pathway and ovarian cancer risk
    Linda E Kelemen
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Res 68:2498-506. 2008
    ..Interventions with modifiable factors such as multivitamin intake may reduce risk...
  50. ncbi request reprint Benign breast disease and the risk of breast cancer
    Lynn C Hartmann
    Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    N Engl J Med 353:229-37. 2005
    ..Benign breast disease is an important risk factor for breast cancer. We studied a large group of women with benign breast disease to obtain reliable estimates of this risk...
  51. ncbi request reprint Alcohol intake in adolescence and mammographic density
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Int J Cancer 117:837-41. 2005
    ..0-23.4%). However, these associations were not statistically significant (p = 0.27 and p = 0.22, respectively). In summary, there was no evidence that adolescent alcohol use was associated with large and persistent effects on adult PD...
  52. doi request reprint Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer
    Judy C Boughey
    Department of Surgery, Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, 200 First Street, SW, Rochester, MN, USA
    Ann Surg Oncol 17:2702-9. 2010
    ..The aim of this study was to investigate whether contralateral prophylactic mastectomy (CPM) in addition to therapeutic mastectomy (TM) is associated with a survival advantage in high-risk women with breast cancer...
  53. ncbi request reprint Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study
    Dawn M Grabrick
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Detect Prev 27:30-6. 2003
    ..8, 95% C.I.: 0.5-1.2). These results provide little evidence that male relatives in high-risk breast cancer families are at increased risk of prostate cancer...
  54. pmc Identification of a novel percent mammographic density locus at 12q24
    Kristen N Stevens
    Department of Health Sciences Research, Mayo Clinic, Charlton 6 239, 200 First St SW, Rochester, MN 55905, USA
    Hum Mol Genet 21:3299-305. 2012
    ..Understanding the mechanism underlying this association will provide insight into the genetics of breast tissue composition...
  55. pmc Common variation in Nemo-like kinase is associated with risk of ovarian cancer
    Kristen N Stevens
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 21:523-8. 2012
    ..Overexpression of mitotic kinases has been associated with prognosis, histologic grade, and clinical stage in ovarian cancer, but the relationship between inherited variation in these genes and ovarian cancer risk has not been well defined...
  56. ncbi request reprint Breast biopsy utilization: a population-based study
    Karthik Ghosh
    Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Arch Intern Med 165:1593-8. 2005
    ..However, scant data exist regarding the utilization of breast biopsies in the community population...
  57. ncbi request reprint Evaluation of a training program to prepare community health representatives to promote breast and cervix cancer screening among native american women
    Wesley O Petersen
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Cancer Educ 19:237-43. 2004
    ..focus of training? and (2) Does training empower CHRs and, indirectly, their facilities to educate about breast and cervix cancer, promote screening, and teach breast self-exam skills to American Indian and Alaska Native women?..
  58. pmc Factors associated with breast cancer prevention communication between mothers and daughters
    Pamela S Sinicrope
    Behavioral Health Program, Mayo Clinic Rochester College of Medicine, Rochester, Minnesota 55905, USA
    J Womens Health (Larchmt) 17:1017-23. 2008
    ..We examined the degree to which mothers reported providing advice on breast cancer prevention to their daughters, the content of such advice, and correlates of providing such advice...
  59. ncbi request reprint Outcomes of training nurses to conduct breast and cervical cancer screening of Native American women
    Wesley O Petersen
    Department of Health Sciences Research, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA
    Holist Nurs Pract 16:58-79. 2002
    ..Findings show that Native WEB training is associated with increased screening activity at all three levels...
  60. ncbi request reprint Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women
    Paul J Limburg
    Divisions of Gastroenterology and Hepatology and Epidemiology, Mayo Clinic Cancer Center, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 1:202-10. 2003
    ..However, long-term CRC risk estimates among female smokers remain limited and inconsistent. The goal of this prospective study was to assess cigarette smoking and CRC risk, overall and by anatomic subsite, among postmenopausal women...
  61. ncbi request reprint Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women
    Linda E Kelemen
    Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Causes Control 15:1085-93. 2004
    ..These findings suggest that alcohol consumption is inversely related to postmenopausal ovarian cancer, and that the association of folate with ovarian cancer may vary by the amount of alcohol consumed...
  62. pmc Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers
    Paul J Limburg
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 4:1514-21. 2006
    ..To date, few studies have directly examined serum insulin as an indicator of CRC risk, and none have reported associations on the basis of HOMA-IR...
  63. ncbi request reprint Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Epidemiology 13:66-71. 2002
    ..Nulliparity may be more strongly associated with an increased risk of ovarian cancer among women with a family history of breast or ovarian cancer, compared with women who do not have a family history of those cancers...
  64. pmc Germline copy number variation and ovarian cancer survival
    Brooke L Fridley
    Department of Health Sciences Research, Mayo Clinic Rochester, MN, USA
    Front Genet 3:142. 2012
    ..40). Although CNVs that were not well-covered by the Illumina 610 quad array merit investigation, these data suggest no association between inherited CNVs and survival after ovarian cancer...
  65. ncbi request reprint Bilateral oophorectomy and breast cancer risk reduction among women with a family history
    Janet E Olson
    Health Science Research, Mayo Foundation, Rochester, MN 55905, USA
    Cancer Detect Prev 28:357-60. 2004
    ..We investigated whether removal of the ovaries is an appropriate risk reduction option for women at elevated risk of breast cancer based on family history of breast cancer...
  66. ncbi request reprint Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study
    Paul J Limburg
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 101:1872-9. 2006
    ..However, existing data are inconsistent. We investigated CRC risks, overall and by anatomic subsite, within a population-based inception cohort of clinically confirmed type 2 DM subjects...
  67. pmc A latent model for prioritization of SNPs for functional studies
    Brooke L Fridley
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
    PLoS ONE 6:e20764. 2011
    ..13). In summary, the application of the BLVM allows for the systematic integration of multiple SNP "features" for the prioritization of loci for fine-mapping or functional studies, taking into account the uncertainty in ranking...
  68. ncbi request reprint Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer
    Linda E Kelemen
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Cancer Epidemiol Biomarkers Prev 14:2168-72. 2005
    ..The association of multivitamin intake with ovarian cancer may depend on FRalpha expression level...
  69. ncbi request reprint Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers
    Camilo Adem
    Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Cancer 97:1-11. 2003
    ....
  70. ncbi request reprint Case-control study of increased mammographic breast density response to hormone replacement therapy
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Epidemiol Biomarkers Prev 11:1382-8. 2002
    ..Because all risk factors examined accounted for only 26% of the variation in the HRT response, genes or other unmeasured factors are thought to be involved...
  71. ncbi request reprint Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance
    Marlene H Frost
    Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 23:7849-56. 2005
    ..The purpose of this research is to evaluate women's long-term satisfaction with CPM, factors influencing satisfaction, and psychological and social function after CPM...
  72. ncbi request reprint TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors
    Colleen S Sinclair
    Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Cancer Res 62:3587-91. 2002
    ..TBX2 was determined to be preferentially amplified and overexpressed in BRCA1 and BRCA2 mutant tumors, whereas RPS6KB1 was not, suggesting a role for TBX2 amplification in the development of BRCA1- and BRCA2-associated breast tumors...
  73. ncbi request reprint Reoperations after prophylactic mastectomy with or without implant reconstruction
    Sara M Zion
    New York Presbyterian Hospital, Weill Cornell Medical Center, New York, New York, USA
    Cancer 98:2152-60. 2003
    ..The authors characterized the unanticipated reoperations after prophylactic mastectomy, with or without implant reconstruction...
  74. doi request reprint Dietary patterns and breast density in the Minnesota Breast Cancer Family Study
    Marilyn Tseng
    Division of Population Science, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA
    Cancer Causes Control 19:481-9. 2008
    ..Whether dietary patterns, rather than single foods or nutrients, are associated with breast density is not known. We investigated this in the Minnesota Breast Cancer Family Study...
  75. ncbi request reprint Genetic ancestry and molecular epidemiology
    Thomas A Sellers
    Cancer Epidemiol Biomarkers Prev 13:499-500. 2004
  76. ncbi request reprint Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies
    Eunyoung Cho
    Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Harvard School of Public Health, and Harvard Center for Cancer Prevention, Boston, Massachusetts 02115, USA
    Ann Intern Med 140:603-13. 2004
    ..However, findings related to specific alcoholic beverages or different anatomic sites in the large bowel have been inconsistent...
  77. ncbi request reprint Mammographic density of the breast
    Celine M Vachon
    N Engl J Med 348:174-5; author reply 174-5. 2003
  78. ncbi request reprint Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
    Simon A Gayther
    Translational Research Laboratories, University College London, London, United Kingdom
    Cancer Res 67:3027-35. 2007
    ..This study highlights the need for multicenter collaborations for genetic association studies...
  79. ncbi request reprint Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
    Thomas A Sellers
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Cancer Causes Control 18:505-15. 2007
    ..Our findings suggest that breast cancer risk may be increased among women with type II diabetes, but that type II diabetes does not significantly influence mammographic breast density...
  80. ncbi request reprint No association between 25-hydroxyvitamin D and mammographic density
    Julia A Knight
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 5th Floor, 60 Murray Street, Toronto, Ontario, Canada M5G 1X5
    Cancer Epidemiol Biomarkers Prev 15:1988-92. 2006
    ..Unlike some previous reports, vitamin D does not seem to be related to mammographic density in this cohort...
  81. pmc Can genes for mammographic density inform cancer aetiology?
    Linda E Kelemen
    Department of Population Health Research, Alberta Cancer Board, 1, 331 29th Street North West, Calgary, Alberta T2N 4N2, Canada
    Nat Rev Cancer 8:812-23. 2008
    ..In this Perspective, we review the limited genetic studies of MD and propose future directions...
  82. ncbi request reprint Estrogen bioactivation, genetic polymorphisms, and ovarian cancer
    Thomas A Sellers
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33602, USA
    Cancer Epidemiol Biomarkers Prev 14:2536-43. 2005
    ..015). Although preliminary, this study provides some support for the hypothesis that low-penetrance susceptibility alleles may influence risk of epithelial ovarian cancer...
  83. ncbi request reprint Preventive health behaviors and familial breast cancer
    Lisa Madlensky
    University of California San Diego Cancer Center, 9500 Gilman Drive, La Jolla, CA 92093 0901, USA
    Cancer Epidemiol Biomarkers Prev 14:2340-5. 2005
    ..To examine medical and lifestyle preventive behaviors among women with varying levels of familial breast cancer risk...
  84. doi request reprint Familial and perceived risk of breast cancer in relation to use of complementary medicine
    Cynthia D Myers
    H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MRC PSY, Tampa, FL 33617, USA
    Cancer Epidemiol Biomarkers Prev 17:1527-34. 2008
    ..To examine the use of complementary and alternative medicine (CAM) by women with varying levels of familial and perceived risk of breast cancer with the goal of preventing breast cancer...
  85. ncbi request reprint Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies
    Jo L Freudenheim
    Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo, NY 14214, USA
    Am J Clin Nutr 82:657-67. 2005
    ..Although smoking is the primary cause of lung cancer, much is unknown about lung cancer etiology, including risk determinants for nonsmokers and modifying factors for smokers...
  86. pmc Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states
    Dana E Rollison
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Am J Epidemiol 167:447-56. 2008
    ..54, 95% confidence interval: 0.37, 0.79). In this study, diabetes was not associated with breast cancer overall, although the inverse association with gestational diabetes warrants further investigation...
  87. ncbi request reprint Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study
    Michelle Harvie
    Univeristy Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom
    Cancer Epidemiol Biomarkers Prev 14:656-61. 2005
    ..These data suggest prevention of weight gain between age 18 years and menopause or weight loss and maintenance during these years reduces risk of postmenopausal breast cancer...
  88. pmc Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer
    Thomas A Sellers
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
    Cancer Epidemiol Biomarkers Prev 17:397-404. 2008
    ..10 frequency; odds ratio, 0.07; P = 0.01) compared with the most common haplotype (0.39 frequency). These results suggest that genetic polymorphisms in the glycoslyation process may be novel risk factors for ovarian cancer...